<DOC>
	<DOCNO>NCT00681356</DOCNO>
	<brief_summary>Evaluate efficacy , tolerability , safety , pharmacokinetics 4975 patient undergoing total knee replacement</brief_summary>
	<brief_title>Safety Efficacy Study 4975 Patients Undergoing Total Knee Replacement</brief_title>
	<detailed_description>The purpose study evaluate efficacy , tolerability , safety , pharmacokinetics 4975 patient undergo primary unilateral total knee arthroplasty</detailed_description>
	<criteria>Key Male female age 18 85 year American Society Anesthesiologists ( ASA ) status I , II , III Planning undergo primary unilateral Total Knee Arthroplasty ( TKA ) Key A body mass index ( BMI ) great 43 Known bleed disorder take agent affect coagulation preoperatively Use medication medical condition investigator 's opinion could adversely impact patient 's participation safety , conduct study , interfere pain assessment Diabetes mellitus know HbA1C &gt; 9.5 history prolong uncontrolled diabetes Previous knee arthroplasty ( partial total ) knee Participated another clinical trial within 30 day prior plan TKA surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>TKA</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Total knee replacement</keyword>
	<keyword>Knee surgery</keyword>
</DOC>